267 results for author: Dr. Daniel Cameron

At least 50% of patients with Lyme neuroborreliosis remain ill years after treatment

There continues to be physicians who dispute the potential severity of Lyme disease and its ability to cause chronic illness in patients, even though there are an increasing number of evidence-based studies supporting that finding.

Lyme disease diagnosis almost missed in patient with Babesia

The number of reported cases of Babesiosis has been rising steadily over the past few years. The increase is particularly concerning to health officials given that the tick-borne infection can be difficult to diagnose and can be transmitted unknowingly through blood transfusions.

Could monoclonal antibodies prevent Lyme disease better than a vaccine?

Researchers say they have had “promising results” in developing a unique method to prevent people from becoming infected with Borrelia burgdorferi (Bb), the causative agent of Lyme disease. It does not involve a vaccine, but rather a process which stimulates the immune system to ward off infections.

B. burgdorferi persister cells survive attacks by antibiotics and may contribute to chronic illness in Lyme disease patients

The consensus among the mainstream medical community has been that a short course of antibiotics will eliminate the objective signs of Lyme borreliosis, and the assumption is made, in turn, that patients are cured of the infection. But, studies indicate otherwise. Dr. Emir Hodzic, of Real-Time PCR Research and Diagnostic Core Facility, School of Veterinary Medicine, University of California, Davis, explores the role 'persisters' play in causing chronic Lyme symptoms.

Hundreds of doctors treating Lyme disease with extended use and multiple antibiotics

There are a handful of hot button issues surrounding Lyme disease that are sure to ignite a firestorm of debate within the medical community; among them is the duration of time required to effectively treat the disease.

Politics of Lyme disease turn patients into victims

Hamodia, an internationally-recognized newspaper, recently published a two-part series on Lyme disease, entitled Lyme in the Limelight, which they have gracious given us permission to reprint. The articles provide an in-depth and insightful look at the politics surrounding a disease that affects hundreds of thousands of people each year. And, which after more than four decades, still elicits heated debates within the medical community.

Study volunteers with newly diagnosed Lyme disease needed

The two-tier Lyme disease criteria introduced in 1994 proved to be a poorly sensitive test in actual practice. Studies have shown that only one-third of all well-characterized cases of Lyme disease are positive by the two-tier Lyme disease test. Over the past few years, an increasing number of tests have been introduced to improve the reliability of serologic tests for tick-borne illnesses. These tests include PCR, t-cell, and antigen detection tests.

Physician-turned-patient becomes Lyme advocate

Dr. Neil Spector, a leading researcher and oncologist at Duke University Medical Center, suffered sudden and severe heart problems brought on by Lyme carditis. For years, he went undiagnosed, enduring the waxing and waning of cardiac symptoms, until one day, his situation became so dire, he required a heart transplant. Now recovered, Dr. Spector has become a vocal supporter for other Lyme disease patients, as he shares the realities of Lyme disease in his memoir, Gone in a Heartbeat.

Hundreds of Lyme disease patients in Tennessee

The incidence of Lyme disease (LD) in Tennessee was 7.7 times higher than that reported to the Tennessee Department of Health (TDH) from 2000–2009 in a study reported in the 2013 Journal of the American Medical Informatics Association. [1]

Most cases consistent with Lyme disease are not tested in non-endemic region

A study published in the July issue of Clinical Infectious Diseases examines whether or not positive Lyme disease tests are of diagnostic value in regions, such as North Carolina, that are not considered endemic for the disease. Upon review of the data presented, the reader can better understand the frequency of Lyme disease testing in regions considered to have a low incidence of the illness.